Categories AlphaGraphs, Earnings, Health Care
Bristol-Myers Squibb swings to profit in Q1 2025; revenue drops
Bristol Myers Squibb (NYSE: BMY) reported net profit for the first quarter of 2025, compared to a loss last year. The biotechnology company’s revenues declined 6% in Q1.
Net income attributable to shareholders was $2.46 million or $1.20 per share in the March quarter, compared to a loss of $11.9 billion or $5.89 per share in the comparable period last year. Adjusted profit was $1.80 per share in Q1, compared to a loss per share of $4.40 in the first quarter of 2024.
March-quarter revenues decreased 6% from last year to $11.2 billion. The company raised its full-year 2025 adjusted earnings per share guidance to a range of $6.70 to $7.00.
Prior Performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Key takeaways from Micron’s (MU) first-quarter 2026 results
Micron Technology Inc. (NASDAQ: MU) has reported blockbuster first-quarter results, comfortably beating estimates as strength in data center demand pushed key operating metrics to record levels. Management is now focused
Lennar (LEN) continues to battle a stubbornly difficult housing market
Shares of Lennar Corporation (NYSE: LEN) were down 2% on Thursday. The stock has dropped 17% over the past three months. The homebuilder saw its revenues and profits decline in
DRI Earnings: Darden Restaurants’ Q2 2026 sales and profit rise YoY
Darden Restaurants, Inc. (NYSE: DRI), a leading fine dining restaurant chain, on Thursday reported an increase in sales and adjusted earnings for the second quarter of fiscal 2026. Total sales
